The effects on skin elasticity and hormone levels of blood by long-term ingestion of test food in human: a double-blind, randomized placebo-controlled, parallel comparison study

Not Applicable

• Conditions: Healthy volunteers

• Registration Number: JPRN-UMIN000028924
• Lead Sponsor: DRC Corporation, Ltd. Product Testing Department No.9 Tabuchi Bldg. 3F, 2-10-31, Higashi-Temma, Kita-ku, Osaka Tel: 81-(0)6-6882-1130

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who continuously take a functional food or a supplement. 2) Subjects who continuously take a functional food or quasi-medicine which has same or similar effect with active ingredient of test food. 3) Subjects who frequently intake food which is rich in same active ingredient of test food, or who intake these kind of food during 3 days before and after trial initiation and the last 3 days from the end of trial. 4) Subjects who work on the night shift or the day and night shift. 5) Subjects who are receiving the medical treatment or the prophylactic treatment, or who are diagnosed the need of medical treatment. 6) Subjects who have skin disease or abnormality in skin condition such as atopic dermatitis. 7) Subjects who show the apparent change of skin condition which is not related to the intake of test food at the end of trial compared with the initiation. 8) Subjects who have a past history for the severe disease or abnormality in glucose metabolism, lipid metabolism, liver function, kidney function, cardiovascular system including heart function, respiratory tract, endocrine system and nerve system, or for psychiatric disorder. 9) Subjects who suffer from anemia, or felt sick due to blood collection. 10) Subjects who have a past history of alcoholism or drug addiction. 11) Subjects who have a risk for food allergy. 12) Subjects who show apparent abnormality in blood test, or who are positive for HBs antigen or HCV antibody in trial duration including the screening period. 13) Subjects who are pregnant or during lactation when the informed consent is provided, or who hope to become pregnant during the trial. 14) Subjects who were involved in another trial within 4 weeks prior to this trial, who will participate in another trial. 15) Subjects who are judged to be inappropriate for this trial by the doctor who is responsible for this trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified